ABVC BIOPHARMA, INC. (ABVC)
About ABVC BIOPHARMA, INC.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $509.6K
- Net income
- -$7.9M
- Total assets
- $21.1M
- Market cap
- $34.6M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $7.2M
- Operating income
- -$7.2M
- Income tax
- $24.2K
- Net income
- -$8.4M
- EPS (basic)
- $-0.39
- EPS (diluted)
- $-0.39
Balance sheet
- Total assets
- $21.1M
- Current assets
- $2.5M
- Total liabilities
- $7.8M
- Current liabilities
- $6.2M
- Shareholders’ equity
- $13.3M
Cash flow
- Operating cash flow
- -$3.0M
- Investing cash flow
- -$1.2M
- Financing cash flow
- $4.6M
- Net cash flow
- $463.2K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $34.6M
- EPS (diluted)
- $-0.39
- Shares outstanding
- 30.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 9, 2004
Abvc Biopharma, Inc. (ABVC) Stock Price
- Reported a net loss of $7.9M in FY2024.
- Trading 76% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ABVC BIOPHARMA, INC..
Write a review
News about ABVC BIOPHARMA, INC.
News & sentiment via Polygon.io
Abvc Biopharma, Inc.: frequently asked questions
Is Abvc Biopharma, Inc. an American company?
Abvc Biopharma, Inc. is a US-based company headquartered in Fremont, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Abvc Biopharma, Inc. headquartered?
Abvc Biopharma, Inc. is headquartered in Fremont, California, United States.
Is Abvc Biopharma, Inc. publicly traded?
Yes — Abvc Biopharma, Inc. is a publicly traded company. Its stock trades under the ticker symbol ABVC on the NASDAQ.
What does Abvc Biopharma, Inc. do?
Abvc Biopharma, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
